Parabilis Medicines, Inc. (PBLS)

NASDAQ: PBLS · Real-Time Price · USD

31.96

+0.14 (0.44%)

At close: Jul 28, 2026, 4:00 PM EDT

31.75

-0.21 (-0.65%)

After-hours: Jul 28, 2026, 7:34 PM EDT

Parabilis Medicines Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-152.08	-152.08	-126.13
Net Income	-186.93	-186.93	-161.48
Earnings Per Share	-92.40	-92.40	-83.48
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	27.71	27.71	87.98
Total Debt	58.7	58.7	66.2
Net Cash (Debt)	-30.99	-30.99	21.78
Net Cash Growth	-	-	-
Net Cash Per Share	-15.32	-15.32	11.26

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-123.71	-123.71	-103.61
Capital Expenditures	-0.31	-0.31	-0.88
Free Cash Flow	-124.02	-124.02	-104.49
Free Cash Flow Growth	-	-	-